A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00908778
Verified October 2009 by Vitreoretinal Technologies, Inc.. Recruitment status was: Recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
50 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects with a history of systemic diabetes(type I,or II)
Subject with a documented history of Non- proliferative Diabetic Retinopathy(NPDR)
Subjects with no or partial PVD at baseline exam in study eye.
Subjects with retinal pathology in the study eye other then (NPDR)
Subjects with high myopia in the study eye
Subjects who have monocular vision or central lateral vision of 20/200 or worse BCVA in the non-study eye.
Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery less then 6 months prior to study enrollment.
Subjects that have either vitrectomy surgery, intavitreal injections, or laser treatments in the study eye.